<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38256526</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>High Plasma Osteopontin Levels Are Associated with Serious Post-Acute-COVID-19-Related Dyspnea.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">392</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13020392</ELocationID><Abstract><AbstractText>COVID-19 survivors commonly report persistent symptoms. In this observational study, we investigated the link between osteopontin (OPN) and post-acute COVID-19 symptoms and lung functional/imaging abnormalities. We recorded symptoms and lung imaging/functional data from previously hospitalized COVID-19 patients, who were followed for 4-84 weeks (122 patients/181 visits) post-symptom onset at our outpatient clinic. Circulating OPN was determined using ELISA. Plasma OPN levels were higher in symptomatic patients (compared with the asymptomatic ones); those with dyspnea (compared with those without dyspnea);those with a combination of serious symptoms, i.e., the presence of at least one of the following: dyspnea, fatigue and muscular weakness (compared with those with none of these symptoms); and those with dyspnea and m-MRC &gt; 1 (compared with those with m-MRC = 0-1). Plasma OPN levels were inversely correlated with EQ-VAS (visual analog scale of the EQ-5D-5L health-related quality-of-life questionnaire) values. High-resolution CT or diffusion lung capacity (DLCO) findings were not related to circulating OPN. In the multiple logistic regression, the presence of symptoms, dyspnea, or the combination of serious symptoms were linked to female gender, increased BMI and pre-existing dyspnea (before the acute disease), while increased plasma OPN levels, female gender and pre-existing dyspnea with m-MRC &gt; 1 were independently associated with severe post-COVID-19 dyspnea (m-MRC &gt; 1). Using a correlation matrix to investigate multiple correlations between EQ-VAS, OPN and epidemiological data, we observed an inverse correlation between the OPN and EQ-VAS values. Increased circulating OPN was linked to the persistence of severe exertional dyspnea and impaired quality of life in previously hospitalized COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pappas</LastName><ForeName>Apostolos G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0002-0908-5763</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eleftheriou</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlahakos</LastName><ForeName>Vassilios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magkouta</LastName><ForeName>Sophia F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>"Marianthi Simou Laboratory", First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riba</LastName><ForeName>Theofani</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dede</LastName><ForeName>Konstantina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siampani</LastName><ForeName>Rafaela</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kompogiorgas</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, "Evangelismos" General Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polydora</LastName><ForeName>Eftychia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papalampidou</LastName><ForeName>Athanasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loutsidi</LastName><ForeName>Natasa-Eleni</ForeName><Initials>NE</Initials><Identifier Source="ORCID">0000-0003-3117-6001</Identifier><AffiliationInfo><Affiliation>Hematology-Lymphomas Department and Bone Marrow Transplant Unit, "Evangelismos" General Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of CT-MRI, "Evangelismos" General Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavernaraki</LastName><ForeName>Ekaterini</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of CT-MRI, "Evangelismos" General Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Exarchos</LastName><ForeName>Demetrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of CT-MRI, "Evangelismos" General Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalomenidis</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>First Department of Critical Care and Pulmonary Medicine, "Evangelismos" General Hospital, School of Medicine, National and Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">osteopontin</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>23</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38256526</ArticleId><ArticleId IdType="pmc">PMC10816040</ArticleId><ArticleId IdType="doi">10.3390/jcm13020392</ArticleId><ArticleId IdType="pii">jcm13020392</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  WHO News Room.  [(accessed on 16 July 2023)].  Available online:  www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition-7; December 2022.</Citation></Reference><Reference><Citation>Montani D., Savale L., Noel N., Meyrignac O., Colle R., Gasnier M., Corruble E., Beurnier A., Jutant E.-M., Pham T., et al. Post-acute COVID-19 syndrome. Eur. Respir. Rev. 2022;31:210185. doi: 10.1183/16000617.0185-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Parotto M., Gy&#xf6;ngy&#xf6;si M., Howe K., Myatra S.N., Ranzani O., Shankar-Hari M., Herridge M.S. Post-acute sequelae of COVID-19: Understanding and addressing the burden of multisystem manifestations. Lancet Respir. Med. 2023;11:739&#x2013;754. doi: 10.1016/S2213-2600(23)00239-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00239-4</ArticleId><ArticleId IdType="pubmed">37475125</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillie J.K., Lone N.I., Jones S., Shaw A., Hairsine B., Kurasz C., Henson H., Armstrong L., Shenton L., Dobson H., et al. Multiorgan MRI findings after hospitalization with COVID-19 in the UK (C-MORE): A prospective, multicentre, observational cohort study. Lancet Respir. Med. 2023;11:1003&#x2013;1019. doi: 10.1016/s2213-2600(23)00262-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(23)00262-x</ArticleId><ArticleId IdType="pmc">PMC7615263</ArticleId><ArticleId IdType="pubmed">37748493</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S.J., Baldwin M.M., Daynes E., Evans R.A., Greening N.J., Jenkins R.G., Lone N.I., McAuley H., Mehta P., Newman J., et al. Respiratory sequelae of COVID-19: Pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir. Med. 2023;11:709&#x2013;725. doi: 10.1016/S2213-2600(23)00159-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00159-5</ArticleId><ArticleId IdType="pmc">PMC10198676</ArticleId><ArticleId IdType="pubmed">37216955</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa R.G., Cavalcanti A.B., Azevedo L.C.P., Veiga V.C., de Souza D., dos Santos R.d.R.M., Schardosim R.F.d.C., Rech G.S., Trott G., Schneider D., et al. Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study. Intensive Care Med. 2023;49:166&#x2013;177. doi: 10.1007/s00134-022-06953-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06953-1</ArticleId><ArticleId IdType="pmc">PMC9808680</ArticleId><ArticleId IdType="pubmed">36594987</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J., Ben&#xed;tez I.D., Carmona P., Santisteve S., Monge A., Moncus&#xed;-Moix A., Gort-Paniello C., Pinilla L., Carratal&#xe1; A., Zuil M., et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19. Chest. 2021;160:187&#x2013;198. doi: 10.1016/j.chest.2021.02.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.02.062</ArticleId><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., Liu M., Wang Y., Cui D., Wang Y., et al. Health outcomes in people 2 years after surviving hospitalization with COVID-19: A longitudinal cohort study. Lancet Respir. Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.-E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#xe7;er M.A., Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin. Biochem. 2018;59:17&#x2013;24. doi: 10.1016/j.clinbiochem.2018.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2018.07.003</ArticleId><ArticleId IdType="pubmed">30003880</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Wei Y., Chen J., Cui G., Ding Y., Kohanawa M., Xu X., Diao H. Osteopontin Exacerbates Pulmonary Damage in Influenza-Induced Lung Injury. Jpn. J. Infect. Dis. 2015;68:467&#x2013;473. doi: 10.7883/yoken.JJID.2014.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2014.467</ArticleId><ArticleId IdType="pubmed">25866117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb M., Borensztajn K., Crestani B. Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers &#x2013; Insights from the Bench Side. Respiration. 2013;86:441&#x2013;452. doi: 10.1159/000357598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000357598</ArticleId><ArticleId IdType="pubmed">24356558</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardo A., Gibson K., Cisneros J., Richards T.J., Yang Y., Becerril C., Yousem S., Herrera I., Ruiz V., Selman M., et al. Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis. PLoS Med. 2005;2:e251. doi: 10.1371/journal.pmed.0020251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020251</ArticleId><ArticleId IdType="pmc">PMC1198037</ArticleId><ArticleId IdType="pubmed">16128620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayek S.S., Roderburg C., Blakely P., Launius C., Eugen-Olsen J., Tacke F., Ktena S., Keitel V., Luedde M., Giamarellos-Bourboulis E.J., et al. Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19. J. Clin. Med. 2021;10:3907. doi: 10.3390/jcm10173907.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173907</ArticleId><ArticleId IdType="pmc">PMC8432103</ArticleId><ArticleId IdType="pubmed">34501358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonello S., D&#x2019;onghia D., Apostolo D., Matino E., Costanzo M., Casciaro G.F., Croce A., Rizzi E., Zecca E., Pedrinelli A.R., et al. Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients. Viruses. 2023;15:630. doi: 10.3390/v15030630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030630</ArticleId><ArticleId IdType="pmc">PMC10054745</ArticleId><ArticleId IdType="pubmed">36992339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D., Dietrich O., Mari T., von Stillfried S., Ibarra I.L., Mittermaier M., Mache C., Chua R.L., Knoll R., Timm S., et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184:6243&#x2013;6261.e27. doi: 10.1016/j.cell.2021.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Moro-L&#xf3;pez-Menchero P., Cancela-Cilleruelo I., Pardo-Hern&#xe1;ndez A., Hern&#xe1;ndez-Barrera V., Gil-De-Miguel A. Psychometric properties of the Spanish version of the EuroQol-5D-5L in previously hospitalized COVID-19 survivors with long COVID. Sci. Rep. 2022;12:12605. doi: 10.1038/s41598-022-17033-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17033-1</ArticleId><ArticleId IdType="pmc">PMC9307967</ArticleId><ArticleId IdType="pubmed">35871259</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Corral T., Fabero-Garrido R., Plaza-Manzano G., Navarro-Santana M.J., Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., L&#xf3;pez-De-Uralde-Villanueva I. Minimal Clinically Important Differences in EQ-5D-5L Index and VAS after a Respiratory Muscle Training Program in Individuals Experiencing Long-Term Post-COVID-19 Symptoms. Biomedicines. 2023;11:2522. doi: 10.3390/biomedicines11092522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11092522</ArticleId><ArticleId IdType="pmc">PMC10526144</ArticleId><ArticleId IdType="pubmed">37760964</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellos I., Tavernaraki K., Stefanidis K., Michalopoulou O., Lourida G., Korompoki E., Thanou I., Thanos L., Pefanis A., Argyraki A. Chest CT severity score and radiological patterns as predictors of disease severity, ICU admission, and viral positivity in COVID-19 patients. Respir. Investig. 2021;59:436&#x2013;445. doi: 10.1016/j.resinv.2021.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7972804</ArticleId><ArticleId IdType="pubmed">33820751</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M., Bernheim A., Mei X., Zhang N., Huang M., Zeng X., Cui J., Xu W., Yang Y., Fayad Z.A., et al. CT imaging features of 2019 novel coronavirus (2019&#x2013;nCoV) Radiology. 2020;295:202&#x2013;207. doi: 10.1148/radiol.2020200230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200230</ArticleId><ArticleId IdType="pmc">PMC7194022</ArticleId><ArticleId IdType="pubmed">32017661</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamissi F.Z., Ning L., Kefaloyianni E., Dun H., Arthanarisami A., Keller A., Atkinson J.J., Li W., Wong B., Dietmann S., et al. Identification of kidney injury released circulating Osteopontin as causal agent of respiratory failure. Sci. Adv. 2022;8:eabm5900. doi: 10.1126/sciadv.abm5900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm5900</ArticleId><ArticleId IdType="pmc">PMC8880785</ArticleId><ArticleId IdType="pubmed">35213222</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., Leavy O.C., Richardson M., Elneima O., McCauley H.J.C., Shikotra A., Singapuri A., Sereno M., Saunders R.M., Harris V.C., et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalization in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutant E.-M., Meyrignac O., Beurnier A., Ja&#xef;s X., Pham T., Morin L., Boucly A., Bulifon S., Figueiredo S., Harrois A., et al. Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome. ERJ Open Res. 2022;8:00479&#x2013;2021. doi: 10.1183/23120541.00479-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00479-2021</ArticleId><ArticleId IdType="pmc">PMC8685862</ArticleId><ArticleId IdType="pubmed">35445129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesinghe D.K.W., Mackie E.J., Pagel C.N. Normal inflammation and regeneration of muscle following injury require osteopontin from both muscle and non-muscle cells. Skelet. Muscle. 2019;9:6. doi: 10.1186/s13395-019-0190-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-019-0190-5</ArticleId><ArticleId IdType="pmc">PMC6390361</ArticleId><ArticleId IdType="pubmed">30808406</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., Ward H., Elliott P. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post&#x2212;COVID-19 Condition. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas A.G., Chaliasou A.-L., Panagopoulos A., Dede K., Daskalopoulou S., Moniem E., Polydora E., Grigoriou E., Psarra K., Tsirogianni A., et al. Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids. Viruses. 2022;15:51. doi: 10.3390/v15010051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010051</ArticleId><ArticleId IdType="pmc">PMC9865280</ArticleId><ArticleId IdType="pubmed">36680091</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>